Russian Corporation for Nanotechnologies ROSNANO

The joint stock company "ROSNANO" was established in March 2011 through the reorganization of the previously existing state corporation "Russian Corporation for Nanotechnologies". "ROSNANO" implements state policy on the development of the domestic nanoindustry, acting as an ideologist and co-investor in nanotechnology projects whose realization is expected to make a significant economic or social contribution to the development and strengthening of the Russian economy and its rearmament. Today the sole shareholder of "ROSNANO" is the state, which owns 100% of the company's shares. Anatoly Chubais has been appointed Chairman of the Board of JSC "ROSNANO".

Nanotechnology is, for Russia as for most developed countries with a high scientific and production potential, one of the most promising directions in the development of science, technology, and industry. The task of innovative development of Russia - the commercialization of promising developments, as well as the problem of rational use of resources - dictates the need to master and apply new instruments of state policy.

Objectives of "ROSNANO"

In order to promote the implementation of state policy in the field of nanotechnology, the development of innovative infrastructure in the field of nanotechnology, and the realization of projects creating promising nanotechnologies and nanoindustry, and in accordance with the Federal Law "On the Russian Corporation for Nanotechnologies", the state corporation "Russian Corporation for Nanotechnologies" was created, later transformed into a joint stock company. The main efforts and resources of "ROSNANO" are planned to be focused on achieving the key objective of "ROSNANO" — securing Russia's leading positions in world markets for nanotechnology products.

Tasks of "ROSNANO"

Based on the main objective set, the Corporation's primary tasks are defined — ensuring the commercialization of nanoindustry developments and coordinating innovative activity in the field of nanoindustry.

Project co-financing

To achieve the main objective and solve the primary tasks, "ROSNANO" uses various enabling instruments, one of which is project co-financing. JSC "ROSNANO" finances promising projects in the field of nanotechnology. Priority is given to projects at the stage closest to market entry.

"ROSNANO" and medical nanotechnology

In the course of carrying out these tasks, in 2008 the supervisory board of the Russian Corporation for Nanotechnologies (ROSNANO) recommended that the board approve an investment deal to finance the medical project "Development, design and construction of the high-tech scientific-production complex 'Beta' for the production of medical equipment".

The implementation of the investment deal and the operational activity of the project company are carried out in the Russian Federation, using Russia's scientific and technological potential. The Russian Corporation for Nanotechnologies "ROSNANO" invested 1.29 billion rubles into the authorized capital of TRACKPORE TECHNOLOGIES JSC to implement this project.